Our site will be undergoing maintenance from 6 a.m. - 6 p.m. ET on Saturday, May 20. During this time, Bookshop, checkout, and other features will be unavailable. We apologize for the inconvenience.
Cookies must be enabled to use this website.
Book Image Not Available Book Image Not Available

See inside

About the author


Lewis S. Blevins Jr., M.D., is a professor of medicine and neurological surgery at University of California, San Francisco. He is the medical director of the California Center for Pituitary Disorders at the University of California San Francisco and is a co-founder of Pituitary World News. He has authored and edited several books on topics including acromegaly, Cushing's syndrome, The Art of Neuroendocrinology, pituitary tumors, and hypopituitarism. He has also published a travelogue regarding his experiences in Ireland and is currently writing a science fiction novel.
Read more
Book Image Not Available Book Image Not Available

See inside

Diabetes Insipidus
Vasopressin Deficiency and Resistance Explained
by Lewis S. Blevins Jr M.D.

Overview


In "Diabetes Insipidus: Vasopressin Deficiency and Resistance Explained," Blevins offers an in-depth exploration of diabetes insipidus through the lens of a seasoned professional. This book captures a career's worth of insights, from the initial encounter with a young woman suffering from neurosarcoidosis in 1988 to the recent evaluation of a middle-aged man with a history of head trauma in April 2024. The author delves into diagnostic testing, management approaches, and shares a wealth of patient stories and survey data from Pituitary World News. This reflective narrative aims to enhance understanding and inspire new perspectives on this complex disorder. While not providing formal medical advice, the author's personal opinions and experiences offer valuable insights for anyone interested in learning more about diabetes insipidus.
Read more

Description


This book presents an overview of diabetes insipidus and represents Lewis Blevins' thoughts, understanding, and personal reflections on a career of evaluating and treating numerous patients with the disorder. In this book, you'll find Blevins' opinions about diagnostic testing and management approaches. He shares patient stories and discusses his findings, as well as patient voices collected from surveys conducted at Pituitary World News. The first patient Blevins encountered with diabetes insipidus was a young woman with neurosarcoidosis in 1988. The most recent patient is a middle-aged man with a history of head trauma, evaluated in April 2024. Blevins has seen and learned a great deal over the years, with much more to explore. His hope is that readers will gain new insights from this book. He does not offer formal recommendations or direct guidance for patients, but rather expresses his personal opinions. Blevins has grappled with whether to use the terms vasopressin deficiency or resistance in place of diabetes insipidus throughout the book. He believes diabetes insipidus is an excellent catch-all term, prevalent in medical literature. Though it may not be the best term for patients, it has been widely used for a long time, describing the clinical syndrome of passing large amounts of tasteless urine. The newer terms describe the underlying pathophysiology. Blevins does not have much hope for doctors' familiarity with this disorder, given its extreme rarity with a prevalence of approximately one in 25,000 persons. Most physicians have not seen a patient with this condition and likely never will. Blevins had the fortune of encountering two cases during his residency and numerous others since his fellowship, where he focused on pituitary disorders. Despite agreeing that the name should be changed, Blevins suspects that diabetes insipidus will remain in use for some time, at least for his generation and a few generations to come. However, he has started referring to vasopressin deficiency along with diabetes insipidus when teaching about this condition. He believes it will take a while for this movement to gain momentum, but encourages patients to educate their healthcare providers with passion, regardless of the terminology. By doing so, they can make a positive difference in the world.
Read more

Overview


In "Diabetes Insipidus: Vasopressin Deficiency and Resistance Explained," Blevins offers an in-depth exploration of diabetes insipidus through the lens of a seasoned professional. This book captures a career's worth of insights, from the initial encounter with a young woman suffering from neurosarcoidosis in 1988 to the recent evaluation of a middle-aged man with a history of head trauma in April 2024. The author delves into diagnostic testing, management approaches, and shares a wealth of patient stories and survey data from Pituitary World News. This reflective narrative aims to enhance understanding and inspire new perspectives on this complex disorder. While not providing formal medical advice, the author's personal opinions and experiences offer valuable insights for anyone interested in learning more about diabetes insipidus.

Read more

Description


This book presents an overview of diabetes insipidus and represents Lewis Blevins' thoughts, understanding, and personal reflections on a career of evaluating and treating numerous patients with the disorder. In this book, you'll find Blevins' opinions about diagnostic testing and management approaches. He shares patient stories and discusses his findings, as well as patient voices collected from surveys conducted at Pituitary World News. The first patient Blevins encountered with diabetes insipidus was a young woman with neurosarcoidosis in 1988. The most recent patient is a middle-aged man with a history of head trauma, evaluated in April 2024. Blevins has seen and learned a great deal over the years, with much more to explore. His hope is that readers will gain new insights from this book. He does not offer formal recommendations or direct guidance for patients, but rather expresses his personal opinions. Blevins has grappled with whether to use the terms vasopressin deficiency or resistance in place of diabetes insipidus throughout the book. He believes diabetes insipidus is an excellent catch-all term, prevalent in medical literature. Though it may not be the best term for patients, it has been widely used for a long time, describing the clinical syndrome of passing large amounts of tasteless urine. The newer terms describe the underlying pathophysiology. Blevins does not have much hope for doctors' familiarity with this disorder, given its extreme rarity with a prevalence of approximately one in 25,000 persons. Most physicians have not seen a patient with this condition and likely never will. Blevins had the fortune of encountering two cases during his residency and numerous others since his fellowship, where he focused on pituitary disorders. Despite agreeing that the name should be changed, Blevins suspects that diabetes insipidus will remain in use for some time, at least for his generation and a few generations to come. However, he has started referring to vasopressin deficiency along with diabetes insipidus when teaching about this condition. He believes it will take a while for this movement to gain momentum, but encourages patients to educate their healthcare providers with passion, regardless of the terminology. By doing so, they can make a positive difference in the world.

Read more

Book details

Genre:MEDICAL

Subgenre:Endocrinology & Metabolism

Language:English

Pages:88

eBook ISBN:9798350972009

Paperback ISBN:9798350971996


Overview


In "Diabetes Insipidus: Vasopressin Deficiency and Resistance Explained," Blevins offers an in-depth exploration of diabetes insipidus through the lens of a seasoned professional. This book captures a career's worth of insights, from the initial encounter with a young woman suffering from neurosarcoidosis in 1988 to the recent evaluation of a middle-aged man with a history of head trauma in April 2024. The author delves into diagnostic testing, management approaches, and shares a wealth of patient stories and survey data from Pituitary World News. This reflective narrative aims to enhance understanding and inspire new perspectives on this complex disorder. While not providing formal medical advice, the author's personal opinions and experiences offer valuable insights for anyone interested in learning more about diabetes insipidus.

Read more

Description


This book presents an overview of diabetes insipidus and represents Lewis Blevins' thoughts, understanding, and personal reflections on a career of evaluating and treating numerous patients with the disorder. In this book, you'll find Blevins' opinions about diagnostic testing and management approaches. He shares patient stories and discusses his findings, as well as patient voices collected from surveys conducted at Pituitary World News. The first patient Blevins encountered with diabetes insipidus was a young woman with neurosarcoidosis in 1988. The most recent patient is a middle-aged man with a history of head trauma, evaluated in April 2024. Blevins has seen and learned a great deal over the years, with much more to explore. His hope is that readers will gain new insights from this book. He does not offer formal recommendations or direct guidance for patients, but rather expresses his personal opinions. Blevins has grappled with whether to use the terms vasopressin deficiency or resistance in place of diabetes insipidus throughout the book. He believes diabetes insipidus is an excellent catch-all term, prevalent in medical literature. Though it may not be the best term for patients, it has been widely used for a long time, describing the clinical syndrome of passing large amounts of tasteless urine. The newer terms describe the underlying pathophysiology. Blevins does not have much hope for doctors' familiarity with this disorder, given its extreme rarity with a prevalence of approximately one in 25,000 persons. Most physicians have not seen a patient with this condition and likely never will. Blevins had the fortune of encountering two cases during his residency and numerous others since his fellowship, where he focused on pituitary disorders. Despite agreeing that the name should be changed, Blevins suspects that diabetes insipidus will remain in use for some time, at least for his generation and a few generations to come. However, he has started referring to vasopressin deficiency along with diabetes insipidus when teaching about this condition. He believes it will take a while for this movement to gain momentum, but encourages patients to educate their healthcare providers with passion, regardless of the terminology. By doing so, they can make a positive difference in the world.

Read more

About the author


Lewis S. Blevins Jr., M.D., is a professor of medicine and neurological surgery at University of California, San Francisco. He is the medical director of the California Center for Pituitary Disorders at the University of California San Francisco and is a co-founder of Pituitary World News. He has authored and edited several books on topics including acromegaly, Cushing's syndrome, The Art of Neuroendocrinology, pituitary tumors, and hypopituitarism. He has also published a travelogue regarding his experiences in Ireland and is currently writing a science fiction novel.

Read more